Skip to main content
Erschienen in: Annals of Nuclear Medicine 4/2014

01.05.2014 | Original Article

Bone uptake of Tc-99m MIBI in patients with hyperparathyroidism

verfasst von: Yunyun Zhao, Qian Wang

Erschienen in: Annals of Nuclear Medicine | Ausgabe 4/2014

Einloggen, um Zugang zu erhalten

Abstract

Objective

The study aimed to investigate the incidence of bone uptake of tracer on Tc-99m MIBI imaging and explore its influencing factors and significance for diagnosis of metabolic bone disease (MBD) in patients with hyperparathyroidism (HPT).

Methods

Seventy-nine consecutive patients with histopathologically confirmed HPT (63 primary and 16 secondary) who had preoperative Tc-99m MIBI imaging were retrospectively evaluated. Serum calcium (Ca), phosphorus (P), and intact parathyroid hormone (iPTH) were measured for all patients, and serum alkaline phosphatase (ALP) was measured for 62 patients. Of the 79 patients, 50 underwent bone mineral density (BMD) examination and 30 underwent bone scintigraphy. The incidence and characteristics of abnormal bone uptake of MIBI were recorded. Mann–Whitney test was performed to determine if serum iPTH, Ca, P, ALP, and BMD were different between the patients with and without MIBI bone uptake. Logistic regression analysis was used to analyze the factors that influence the bone uptake of MIBI. The concordance rate between Tc-99m MIBI imaging and bone scintigraphy in delineating MBD was calculated.

Results

Tc-99m MIBI imaging disclosed the abnormal bone uptake of tracer in 22 (27.8 %) patients. Of them, 19 showed diffusely increased activity in skeleton, 2 showed focal uptake in brown tumors, and one showed both above patterns. Patients with bone uptake MIBI had higher level of serum iPTH (Z = −4.34, P < 0.001) and ALP (Z = −3.50, P < 0.001) than those without bone uptake. Logistic regression analysis also showed that bone uptake of MIBI was correlated with serum iPTH (OR = 4.42, P < 0.001) and ALP (OR = 3.21, P = 0.002). Among the 30 patients that underwent bone scintigraphy, 76.7 % patients showed signs of MBD, and the concordance rate between Tc-99m MIBI imaging and bone scintigraphy was 60 % for detecting MBD.

Conclusions

Bone uptake of MIBI in patients with HPT is commonly related to a high level of iPTH and ALP; it probably reflects an active stage of MBD, and it should be monitored during the conventional Tc-99m MIBI scintigraphy.
Literatur
1.
Zurück zum Zitat Park CH, Kim SM, McEwan JR, Intenzo C, Cohn H. Small parathyroid adenoma associated with hyperactive bone demonstrated by Tc-99m MIBI scintiscan. Clin Nucl Med. 1994;19(2):160.PubMedCrossRef Park CH, Kim SM, McEwan JR, Intenzo C, Cohn H. Small parathyroid adenoma associated with hyperactive bone demonstrated by Tc-99m MIBI scintiscan. Clin Nucl Med. 1994;19(2):160.PubMedCrossRef
2.
Zurück zum Zitat Treglia G, Dambra DP, Bruno I, Mulè A, Giordano A. Costal brown tumor detected by dual-phase parathyroid imaging and SPECT-CT in primary hyperparathyroidism. Clin Nucl Med. 2008;33(3):193–5.PubMedCrossRef Treglia G, Dambra DP, Bruno I, Mulè A, Giordano A. Costal brown tumor detected by dual-phase parathyroid imaging and SPECT-CT in primary hyperparathyroidism. Clin Nucl Med. 2008;33(3):193–5.PubMedCrossRef
3.
Zurück zum Zitat Kanis JA, Melton LJ 3rd, Christiansen C, Johnston CC, Khaltaev N. The diagnosis of osteoporosis. J Bone Miner Res. 1994;9(8):1137–41.PubMedCrossRef Kanis JA, Melton LJ 3rd, Christiansen C, Johnston CC, Khaltaev N. The diagnosis of osteoporosis. J Bone Miner Res. 1994;9(8):1137–41.PubMedCrossRef
4.
Zurück zum Zitat Pour MC, Simon-Corat Y, Horne T. Diffuse increased uptake on bone scan: super scan. Semin Nucl Med. 2004;34(2):154–6.PubMedCrossRef Pour MC, Simon-Corat Y, Horne T. Diffuse increased uptake on bone scan: super scan. Semin Nucl Med. 2004;34(2):154–6.PubMedCrossRef
5.
Zurück zum Zitat Mariani G, Gulec SA, Rubello D, Boni G, Puccini M, Pelizzo MR, et al. Preoperative localization and radioguided parathyroid surgery. J Nucl Med. 2003;44(9):1443–58.PubMed Mariani G, Gulec SA, Rubello D, Boni G, Puccini M, Pelizzo MR, et al. Preoperative localization and radioguided parathyroid surgery. J Nucl Med. 2003;44(9):1443–58.PubMed
6.
Zurück zum Zitat Wang Q, Gao BS, Qin SL. Diagnosis of hyperparathyroidism with MRI and 99Tcm-MIBI scintigraphy. Chin J Nucl Med. 2002;22(1):28–30. Wang Q, Gao BS, Qin SL. Diagnosis of hyperparathyroidism with MRI and 99Tcm-MIBI scintigraphy. Chin J Nucl Med. 2002;22(1):28–30.
7.
Zurück zum Zitat Zhao YY, Wang Q, Li Y, Yue MG, Li HB. Parathyroid hormone measurement and 99mTc-MIBI imaging for hyperparathyroidism diagnosis. Chin J Nucl Med. 2011;31(4):263–6. Zhao YY, Wang Q, Li Y, Yue MG, Li HB. Parathyroid hormone measurement and 99mTc-MIBI imaging for hyperparathyroidism diagnosis. Chin J Nucl Med. 2011;31(4):263–6.
9.
Zurück zum Zitat Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD–MBD). Kidney Int Suppl. 2009;113:S1–130. Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD–MBD). Kidney Int Suppl. 2009;113:S1–130.
10.
Zurück zum Zitat Valdemarsson S, Lindergård B, Tibblin S, Bergenfelz A. Increased biochemical markers of bone formation and resorption in primary hyperparathyroidism with special reference to patients with mild disease. J Intern Med. 1998;243(2):115–22.PubMedCrossRef Valdemarsson S, Lindergård B, Tibblin S, Bergenfelz A. Increased biochemical markers of bone formation and resorption in primary hyperparathyroidism with special reference to patients with mild disease. J Intern Med. 1998;243(2):115–22.PubMedCrossRef
11.
Zurück zum Zitat Fogelman I, Bessent RG, Beastall G, Boyle IT. Estimation of skeletal involvement in primary hyperparathyroidism. Use of 24-h-whole body retention of technetium-99m diphosphonate. Ann Intern Med. 1980;92(1):65–7.PubMedCrossRef Fogelman I, Bessent RG, Beastall G, Boyle IT. Estimation of skeletal involvement in primary hyperparathyroidism. Use of 24-h-whole body retention of technetium-99m diphosphonate. Ann Intern Med. 1980;92(1):65–7.PubMedCrossRef
12.
Zurück zum Zitat Fogelman I, Carr D. A comparison of bone scanning and radiology in the evaluation of patients with metabolic bone disease. Clin Radiol. 1980;31(3):321–6.PubMedCrossRef Fogelman I, Carr D. A comparison of bone scanning and radiology in the evaluation of patients with metabolic bone disease. Clin Radiol. 1980;31(3):321–6.PubMedCrossRef
13.
Zurück zum Zitat Nishida H, Kaida H, Ishibashi M, Hiromatsu Y, Baba K, Iida S, et al. Usefulness of bone uptake ratio of bone scintigraphy in hemodialysis patients. Ann Nucl Med. 2005;19(2):91–4.PubMedCrossRef Nishida H, Kaida H, Ishibashi M, Hiromatsu Y, Baba K, Iida S, et al. Usefulness of bone uptake ratio of bone scintigraphy in hemodialysis patients. Ann Nucl Med. 2005;19(2):91–4.PubMedCrossRef
14.
Zurück zum Zitat Jonsson C, Jacobsson H. Accumulation of 99mTc-MIBI in bone marrow. Ann Nucl Med. 1996;10(3):281–5.PubMedCrossRef Jonsson C, Jacobsson H. Accumulation of 99mTc-MIBI in bone marrow. Ann Nucl Med. 1996;10(3):281–5.PubMedCrossRef
15.
Zurück zum Zitat Atasever T, Vural G, Yenidünya S, Ataoğlu O, Atavci S, Unlü M. Tc-99m-MIBI bone marrow uptake in bone marrow fibrosis secondary to metastatic breast carcinoma. Clin Nucl Med. 1997;22(9):655–6.PubMedCrossRef Atasever T, Vural G, Yenidünya S, Ataoğlu O, Atavci S, Unlü M. Tc-99m-MIBI bone marrow uptake in bone marrow fibrosis secondary to metastatic breast carcinoma. Clin Nucl Med. 1997;22(9):655–6.PubMedCrossRef
16.
Zurück zum Zitat Bhadada SK, Sridhar S, Ahluwalia J, Bhansali A, Malhotra P, Behera A, et al. Anemia and thrombocytopenia improves after curative parathyroidectomy in a patient of primary hyperparathyroidism (PHPT). J Clin Endocrinol Metab. 2012;97(5):1420–2.PubMedCrossRef Bhadada SK, Sridhar S, Ahluwalia J, Bhansali A, Malhotra P, Behera A, et al. Anemia and thrombocytopenia improves after curative parathyroidectomy in a patient of primary hyperparathyroidism (PHPT). J Clin Endocrinol Metab. 2012;97(5):1420–2.PubMedCrossRef
Metadaten
Titel
Bone uptake of Tc-99m MIBI in patients with hyperparathyroidism
verfasst von
Yunyun Zhao
Qian Wang
Publikationsdatum
01.05.2014
Verlag
Springer Japan
Erschienen in
Annals of Nuclear Medicine / Ausgabe 4/2014
Print ISSN: 0914-7187
Elektronische ISSN: 1864-6433
DOI
https://doi.org/10.1007/s12149-014-0818-9

Weitere Artikel der Ausgabe 4/2014

Annals of Nuclear Medicine 4/2014 Zur Ausgabe